SpectRx Reaches Milestones for Non-Invasive Detector
NORCROSS, Ga., Sept. 14 -- SpectRx Inc. has completed milestones valued at $400,000 under its agreement with Roche Diagnostics to develop the Accu-Chek D-Tector, a photonics-based non-invasive diabetes detection device. The milestones reached were the initiation and completion of key device tests and delivery of units to Roche. SpectRx will manufacture the devices, which are to be marketed worldwide by Roche exclusively. Roche also bears responsibility for regulatory approval.
The Accu-Chek D-Tector employs biophotonics -- the technology of using light beams and other forms of energy to...Read full article
Related content from Photonics Media
Published: September 1999